Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.64−0.27 (-2.27%)
Close on Nov 18, 2026Market cap $1.51BP/E –Yield –
Mesoblast market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Mesoblast's market cap was $1.77B on Nov 11, 2026, against $2.08B a year earlier. Over the last 5 years it ranged from $136.88M to $2.18B, with a median of $578.62M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.77B | -18.9% |
| 2025 | Dec 31, 2025 | $2.18B | +11.5% |
| 2024 | Dec 31, 2024 | $1.95B | +1041.8% |
| 2023 | Dec 29, 2023 | $171.10M | -57.7% |
| 2022 | Dec 30, 2022 | $404.42M | -32.2% |
| 2021 | Dec 31, 2021 | $596.67M | -36.1% |
| 2020 | Dec 31, 2020 | $933.32M | +27.3% |
| 2019 | Dec 31, 2019 | $733.09M | +87.5% |
| 2018 | Dec 31, 2018 | $391.05M | -16.1% |
| 2017 | Dec 29, 2017 | $466.08M | +19.6% |
| 2016 | Dec 30, 2016 | $389.70M | – |
See a number that looks wrong?